Transcriptome profiling of PRMT5/MEP50 shRNA knockdown lung cancer models identified differential expression of components of the TGFβ pathway, suggesting that PRMT5 may be important for the TGFβ response and subsequent cancer metastasis (46). Here, PRMT5 is linked to lung carcinoma.